Cargando…
Survival impact of adherence to tyrosine kinase inhibitor in chronic myeloid leukemia
BACKGROUND/AIMS: Adherence to tyrosine kinase inhibitors (TKIs) has become a critical aspect of care in chronic myeloid leukemia (CML). We aimed to examine the association of TKI adherence with overall survival (OS) outcomes in Korean patients diagnosed with CML and treated with TKIs using data from...
Autores principales: | Kim, Yundeok, Go, Tae-Hwa, Jang, Jaeyeon, Lee, Jii Bum, Lim, Seung Taek, Shim, Kwang Yong, Lee, Jong In, Kong, Jee Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588973/ https://www.ncbi.nlm.nih.gov/pubmed/34742178 http://dx.doi.org/10.3904/kjim.2021.158 |
Ejemplares similares
-
High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea
por: Kong, Jee Hyun, et al.
Publicado: (2022) -
Characteristics and survival of patients with atypical chronic myeloid leukemia
por: Kong, Jee Hyun, et al.
Publicado: (2019) -
PB2348: OUTCOME OF VERY ELDERLY DIFFUSE LARGE B CELL LYMPHOMA, SINGLE CENTER EXPERIENCE, RETROSPECTIVE ANALYSIS
por: Kong, Jee Hyun, et al.
Publicado: (2023) -
Chronic myeloid leukemia patients’ adherence to peroral tyrosine kinase inhibitors compared with adherence as estimated by their physicians
por: Kekäle, Meri, et al.
Publicado: (2014) -
Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia
por: de Almeida, Maria Helena, et al.
Publicado: (2014)